HLA-DRB1 alleles and Jka immunization

Transfusion

Volumn 45, Issue 6, 2005, Pages 956-959

  Reviron, Denis ^a   Dettori, Isabelle ^a   Ferrera, Virginie ^a   Legrand, Dominique ^a   Touinssi, Mhammed ^a   Mercier, Pierre ^a   De Micco, Philippe ^a   Chiaroni, Jacques ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIBODY; BLOOD GROUP ANTIGEN; BLOOD GROUP JK A ANTIBODY; BLOOD GROUP JK A ANTIGEN; HLA DR ANTIGEN; PRIMER DNA; UNCLASSIFIED DRUG;

ALLELE; ANTIBODY PRODUCTION; ARTICLE; BLOOD GROUP KIDD SYSTEM; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FRANCE; GENE FREQUENCY; GENE SEQUENCE; GENETIC PREDISPOSITION; GENOTYPE; HLA SYSTEM; HUMAN; HYBRIDIZATION; IMMUNIZATION; MALE; OLIGONUCLEOTIDE PROBE; SEQUENCE ANALYSIS;

ALLELES; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; FEMALE; FRANCE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; IMMUNIZATION; INFANT, NEWBORN; KIDD BLOOD-GROUP SYSTEM; MALE; PREGNANCY;

EID: 20444376472     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.04366.x     Document Type: Article

References (10)

1. Polesky HF, Bove JR. A fatal hemolytic transfusion reaction with acute autohemolysis. Transfusion 1964;4:285-92.
2. Yates J, Howell P, Overfield J, et al. IgG anti-Jka/Jkb antibodies are unlikely to fix complement. Transfus Med 1998;8:133-40.
3. Pineda AA, Taswell HF, Brzica SM. Delayed hemolytic transfusion reaction: an immunologic hazard of blood transfusion. Transfusion 1978;18:1-7.
4. Stern LJ, Brown JH, Jardetzky TS, et al. Crystal structure of the human class II MHC protein HLA-DRI complexed with an influenza virus peptide. Nature 1994;368:215-21.
5. Wucherpfennig KW, Yu B, Bhol K, et al. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci U S A 1995;92:11935-9.
6. Bignon JD, Fernandez-Vina M. PCR-SSO protocol for the HLA-DNA typing technique. In: Charron D, Fauchet R, editors. Twelfth international histocompatibility workshop reference protocol addendum: technical handbook. Paris: EDK, 1996.
7. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-35.
8. Haldane JB. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956;20:309-11.
9. Bodmer JG, Marsh SG, Albert ED, et al. Nomenclature for factors of the HLA system, 1995. Eur J Immunogenet 1995;22:335-60.
10. Kirschmann DA, Duffin KL, Smith CE, et al. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles. J Immunol 1995; 155:5655-62.